Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-14-002821

Director bought 2,000,000 shares at $2.52 ($5,040,000)

From the SEC's structured data for this filing

Trades in this filing

BROADWOOD PARTNERS LP · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2014-05-01 Purchase : show line 1 in the form +2,000,000 $2.52 $5,040,000 11,822,262 D
2014-05-01 Purchase : show line 2 in the form +0 11,822,262 I
Open-market purchases · 2,000,000 sh · avg $2.52 · $5,040,000
Loading xslF345X03/p1474701.xml…